Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials

Objective. To conduct a comprehensive PRISMA-compliant systematic review and meta-analysis to evaluate the efficacy and safety of Chinese medicines (CMs) as an adjuvant therapy for unresectable HCC during transarterial chemoembolization (TACE). Methods. Main databases were searched up to October 201...

詳細記述

保存先:
書誌詳細
主要な著者: Cheung, Fan, Wang, Xuanbin, Wang, Ning, Yuen, Man-Fung, Ziea, Tat-chi, Tong, Yao, Wong, Vivian Taam, Feng, Yibin
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2013
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730382/
https://ncbi.nlm.nih.gov/pubmed/23956773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/487919
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料